[Disturbances of contractile function of the heart in myocardial infarct and the therapeutic use of cofactors of synthesis and precursors of nucleic acids].
D000818:Animals; D001011:Aorta; D001158:Arteries; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002302:Cardiac Output; D003250:Constriction; D004285:Dogs; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D006321:Heart / Q000503:physiopathology*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009119:Muscle Contraction; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism; D009963:Orotic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D012039:Regional Blood Flow; D016276:Ventricular Function; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000627:therapeutic use*
D009963:Orotic Acid; D005492:Folic Acid; D014805:Vitamin B 12
Narusheniia sokratitel'noĭ funktsii serdtsa pri infarkte miokarda i primenenie s terapevticheskoĭ tsel'iu kofaktorov sinteza i predshestvennikov nukleinovykh kislot.